A Two Part Trial Investigating the Safety of NN9924 in Healthy Male Subjects

Exclusion Criteria

• •Known or suspected allergy to trial product or related products
• •Acute infection or inflammation or other illness that may confound the results of the trial or pose a risk to the subject by administering the trial product, as judged by the Investigator
• •Presence of clinically significant acute gastrointestinal symptoms (e.g. nausea, vomiting, heartburn or diarrhoea) or malabsorptive states (celiac disease, lactose intolerance or chronic pancreatitits), as judged by the Investigator